Viridian Therapeutics (VRDN) had the highest return in January 2020 by a mid-cap US stock, returning 253.2%.
| ASSET | MONTH | % RETURN |
|---|---|---|
Viridian Therapeutics (VRDN) | January 2020 | 253.25% |
Acm Research (ACMR) | January 2020 | 85.48% |
Immunitybio (IBRX) | January 2020 | 65.01% |
Skeena Resources (SKE) | January 2020 | 39.82% |
Apellis Pharmaceuticals (APLS) | January 2020 | 32.78% |
Kiniksa Pharmaceuticals (KNSA) | January 2020 | 32.4% |
Liquidia Technologies (LQDA) | January 2020 | 32.35% |
Appian (APPN) | January 2020 | 31.99% |
Denali Therapeutics (DNLI) | January 2020 | 31.89% |
Bill Com (BILL) | January 2020 | 31.18% |
TG Therapeutics (TGTX) | January 2020 | 27.9% |
Agilysys (AGYS) | January 2020 | 27.25% |
Bath & Body Works (BBWI) | January 2020 | 26.9% |
iRhythm Technologies (IRTC) | January 2020 | 24.68% |
VNET Group Inc DRC (VNET) | January 2020 | 23.36% |
Impinj (PI) | January 2020 | 22.64% |
Goosehead Insurance (GSHD) | January 2020 | 22.43% |
Zai Lab (ZLAB) | January 2020 | 22.13% |
Sunrun (RUN) | January 2020 | 21.73% |
Ultragenyx (RARE) | January 2020 | 21.7% |
SLM (SLM) | January 2020 | 21.6% |
Soleno Therapeutics (SLNO) | January 2020 | 21.4% |
Ringcentral (RNG) | January 2020 | 20.93% |
DRDGOLD Limited ADR (DRD) | January 2020 | 20.68% |
Plug Power (PLUG) | January 2020 | 20.56% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
